How Epigenetics Alters Gene Expression Without Changing DNA

Identical DNA, Different Cells: How One Genome Makes 200 Cell Types

Every cell in the human body — from a neuron in the prefrontal cortex to a cardiomyocyte in the heart — carries the same 3.2 billion base pairs of DNA. Yet neurons express genes for ion channels and neurotransmitter receptors that heart cells never activate, while cardiomyocytes express sarcomere proteins that neurons silence. The same genetic text is read differently in each cell type. The mechanism is epigenetics: heritable changes in gene expression that do not alter the underlying DNA sequence, mediated by chemical modifications to DNA and the proteins around which it is wound.

Epigenetics bridges genetics and environment. Diet, stress, toxin exposure, and developmental timing can all modify epigenetic marks, changing which genes are expressed — and these changes can sometimes persist across cell divisions and even, in some organisms, across generations.

DNA Methylation

The most extensively studied epigenetic mark is DNA methylation: the addition of a methyl group (–CH₃) to the cytosine base, typically at CpG dinucleotides (positions where cytosine is followed by guanine). In mammals, approximately 70–80% of CpG sites are methylated in differentiated cells.

• Methylation of CpG islands — clusters of CpG dinucleotides near gene promoters — silences gene expression by blocking transcription factor binding and recruiting methyl-binding proteins that condense chromatin.
• DNA methyltransferases (DNMT1, DNMT3A, DNMT3B) add methyl groups; DNMT1 maintains methylation patterns after DNA replication by methylating the new (hemimethylated) strand.
• Ten-eleven translocation (TET) enzymes remove methylation by oxidising 5-methylcytosine to 5-hydroxymethylcytosine and further oxidised forms, which are then replaced by unmodified cytosine.
• Global DNA hypomethylation and promoter hypermethylation are hallmarks of cancer: tumour suppressor genes are silenced by methylation while genome-wide methylation decreases, destabilising chromosomes.

Histone Modifications

DNA in eukaryotes is wrapped around octamers of histone proteins to form nucleosomes — the fundamental units of chromatin. The N-terminal tails of histones protrude and carry an elaborate code of covalent modifications that regulate chromatin accessibility.

Histone acetylation adds a negative charge to lysine residues, weakening their attraction to the negatively charged DNA backbone. Chromatin opens up, allowing RNA polymerase and transcription factors to access the DNA. Histone deacetylases (HDACs) reverse this, compacting chromatin and silencing genes. HDAC inhibitors are approved cancer drugs (vorinostat, romidepsin) that broadly reactivate silenced tumour suppressor genes.

Chromatin Remodelling and 3D Genome Organisation

Beyond individual marks, large-scale chromatin organisation partitions the genome into active and inactive compartments. The nucleus is not a bag of uniformly distributed DNA — it is organised into topologically associating domains (TADs), compartments, and nuclear territories.

• Active chromatin (euchromatin) is loosely packed and transcriptionally accessible; it resides preferentially in the nuclear interior.
• Inactive chromatin (heterochromatin) is densely packed and gene-poor; it localises near the nuclear envelope.
• ATP-dependent chromatin remodelling complexes (SWI/SNF, ISWI, CHD, INO80 families) use energy to slide, eject, or restructure nucleosomes, creating access points for transcription machinery.
• TADs are megabase-scale domains where DNA sequences preferentially interact; enhancers and their target promoters are typically within the same TAD, constraining which enhancers control which genes.

Epigenetics and Disease

Epigenetic dysregulation contributes to cancer, neurological disorders, metabolic diseases, and ageing. Imprinting disorders demonstrate the consequences clearly. Prader-Willi syndrome and Angelman syndrome both arise from disruptions to a specific region of chromosome 15, but the phenotype depends on which parental allele is affected — because one allele is normally silenced by imprinting (differential methylation) and only the other is expressed.

Epigenetic clocks — mathematical models built on DNA methylation patterns at specific CpG sites — predict biological age more accurately than chronological age. Horvath's 2013 clock, trained on methylation data from 51 tissue types, estimates biological age within 3.6 years. Accelerated epigenetic ageing (high biological age relative to chronological age) correlates with increased risk of cancer, cardiovascular disease, and all-cause mortality.

Transgenerational Epigenetic Inheritance

Whether epigenetic marks are inherited across generations in mammals remains debated but partly confirmed. During gametogenesis and early embryogenesis, the epigenome undergoes broad reprogramming — most methylation is erased and reset. Yet some marks escape this erasure.

The Dutch Hunger Winter (1944–1945) provided a natural human experiment. Children conceived during the famine had altered methylation of the IGF2 (insulin-like growth factor 2) gene decades later, with elevated rates of metabolic disease. Grandchildren of men who experienced prepubertal nutritional surges in Överkalix, Sweden showed altered mortality patterns, suggesting a paternal epigenetic signal transmitted at least two generations. Mechanistic inheritance in plants via small RNAs is well-established; the transmission pathway in mammals likely involves sperm-borne small RNAs and methylation at specific loci that escape reprogramming. The field is actively investigating the full scope and molecular mechanisms of transgenerational epigenetic memory in humans.